Main Street Group’s Verona Pharma VRNA Stock Holding History

Main Street Group’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-400	Closed	-$42.7K	–	605
2025 Q3	$42.7K	Sell	400 -100	-20%	-$10.4K	0.01%	274
2025 Q2	$47.3K	Hold	500	–	–	0.02%	248
2025 Q1	$31.7K	Hold	500	–	–	0.01%	316
2024 Q4	$23.2K	Hold	500	–	–	0.01%	377
2024 Q3	$14.4K	Hold	500	–	–	0.01%	445
2024 Q2	$7.75K	Hold	500	–	–	﹤0.01%	566
2024 Q1	$8.03K	Hold	500	–	–	﹤0.01%	580
2023 Q4	$9.94K	Buy	+500	New	+$7.38K	﹤0.01%	802

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Main Street Group's VRNA Position: Q4 2025 in Review

Main Street Group sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 400 shares — an estimated $42.7K sold.

Main Street Group first reported a position in VRNA in Q4 2023 and held it in 8 quarters. The position peaked at $47.3K in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Main Street Group reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Main Street Group sold 400 Verona Pharma shares in Q4 2025, an estimated $42.7K.
Main Street Group first reported a position in Verona Pharma in Q4 2023 and held it in 8 quarters.
Main Street Group's Verona Pharma position peaked at $47.3K in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Main Street Group's 13F filing for Q4 2025, filed 26 Jan 2026.